Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib
出版年份 2014 全文链接
标题
Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib
作者
关键词
-
出版物
HYPERTENSION
Volume 64, Issue 6, Pages 1282-1289
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2014-09-03
DOI
10.1161/hypertensionaha.114.04187
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma
- (2014) Grégory Verhoest et al. Biomed Research International
- Hypertension During Vascular Endothelial Growth Factor Inhibition: Focus on Nitric Oxide, Endothelin-1, and Oxidative Stress
- (2013) Stephanie Lankhorst et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of Endogenous Vascular Endothelial Growth Factor in Endothelium-Dependent Vasodilation in Humans
- (2013) Anna M.J. Thijs et al. HYPERTENSION
- Vascular Endothelial Growth Factor-A and Aldosterone
- (2013) Carine Gennari-Moser et al. HYPERTENSION
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension
- (2012) Peter Kruzliak et al. ANGIOGENESIS
- Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma
- (2012) G Groenewegen et al. BRITISH JOURNAL OF CANCER
- Endothelin-1 and the kidney - beyond BP
- (2012) Neeraj Dhaun et al. BRITISH JOURNAL OF PHARMACOLOGY
- Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib
- (2012) Tasuku Nagasawa et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Mechanism of hypertension and proteinuria during angiogenesis inhibition
- (2012) Stephanie Lankhorst et al. JOURNAL OF HYPERTENSION
- Renoprotective Effects of Sildenafil in DOCA-Salt Hypertensive Rats
- (2012) Eun Hui Bae et al. KIDNEY & BLOOD PRESSURE RESEARCH
- The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Targeting the endothelin axis in prostate carcinoma
- (2011) Álvaro Pinto et al. TUMOR BIOLOGY
- Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats
- (2010) Yoshihiro Kuno et al. BRITISH JOURNAL OF PHARMACOLOGY
- Which antihypertensive drugs are the most nephroprotective and why?
- (2010) Paolo Cravedi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
- (2010) Mariëtte H.W. Kappers et al. HYPERTENSION
- Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats
- (2010) Joep HM van Esch et al. JOURNAL OF HYPERTENSION
- Podocyte Repopulation Contributes to Regression of Glomerular Injury Induced by Ace Inhibition
- (2009) Daniela Macconi et al. AMERICAN JOURNAL OF PATHOLOGY
- Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
- (2009) Carie S. Facemire et al. HYPERTENSION
- ETA Receptor Blockade With Atrasentan Prevents Hypertension With the Multitargeted Tyrosine Kinase Inhibitor ABT-869 in Telemetry-instrumented Rats
- (2009) Patricia N Banfor et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effective Strategies for Management of Hypertension After Vascular Endothelial Growth Factor Signaling Inhibition Therapy: Results From a Phase II Randomized, Factorial, Double-Blind Study of Cediranib in Patients With Advanced Solid Tumors
- (2009) Marlies H.G. Langenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects
- (2009) Mariëtte HW Kappers et al. JOURNAL OF HYPERTENSION
- Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry
- (2009) Peter de Bruijn et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Effect of the Multitargeted Receptor Tyrosine Kinase Inhibitor, ABT-869 [N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on Blood Pressure in Conscious Rats and Mice: Reversal with Antihypertensive Agents and Effect on Tumor Growth Inhibition
- (2009) P. H. Franklin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
- (2009) Michael A Weber et al. LANCET
- Inhibition of Vascular Endothelial Growth Factor-A Signaling Induces Hypertension: Examining the Effect of Cediranib (Recentin; AZD2171) Treatment on Blood Pressure in Rat and the Use of Concomitant Antihypertensive Therapy
- (2008) J. O. Curwen et al. CLINICAL CANCER RESEARCH
- Nephrin and endothelial injury
- (2008) Peter V Hauser et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- The endothelin axis in cancer
- (2008) Anna Bagnato et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2008) M. Iglarz et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat
- (2007) G Rossoni et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More